Correlation of Decreased Serum Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Levels With Non-motor Symptoms in Patients With Parkinson’s Disease
Objective: Pituitary adenylate-cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) are two neuropeptides that exhibit anti-inflammatory and neuroprotective properties, modulating the production of cytokines and chemokines, and the behavior of immune cells. However, the rel...
Main Authors: | Shiyu Hu, Shen Huang, Jianjun Ma, Dongsheng Li, Zhenxiang Zhao, Jinhua Zheng, Mingjian Li, Zhidong Wang, Wenhua Sun, Xiaoxue Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2021.689939/full |
Similar Items
-
Increased Plasma Heme Oxygenase-1 Levels in Patients With Early-Stage Parkinson’s Disease
by: Wenhua Sun, et al.
Published: (2021-02-01) -
Some studies on adenylate cyclase in brain
by: Ma, Yvonne Suk-Fong
Published: (2011) -
The Neuropeptides Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Control HIV-1 Infection in Macrophages Through Activation of Protein Kinases A and C
by: Jairo R. Temerozo, et al.
Published: (2018-06-01) -
Bordetella Adenylate Cyclase-Hemolysin Toxins
by: Nicole Guiso
Published: (2017-09-01) -
Elevated Plasma Melatonin Levels Are Correlated With the Non-motor Symptoms in Parkinson’s Disease: A Cross-Sectional Study
by: Linyi Li, et al.
Published: (2020-05-01)